NDC: 53002-1029-3 30 TABLET in a BOTTLE
NDC: 53002-1029-0 100 TABLET in a BOTTLE
Store in a tight container protected from light and moisture. Store between 15° — 30°C (59° — 86°F).
All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.
NP Thyroid 1 Grain (60mg) Tablets, USP
| NP THYROID 60
levothyroxine, liothyronine tablet |
|Product Information |
|Product Type ||HUMAN PRESCRIPTION DRUG ||Item Code (Source) ||NDC:53002-1029(NDC:42192-330) |
|Route of Administration ||ORAL ||DEA Schedule || |
|Active Ingredient/Active Moiety |
|Ingredient Name ||Basis of Strength ||Strength |
|LEVOTHYROXINE (LEVOTHYROXINE) ||LEVOTHYROXINE ||38 ug |
|LIOTHYRONINE (LIOTHYRONINE) ||LIOTHYRONINE ||9 ug |
|Inactive Ingredients |
|Ingredient Name ||Strength |
| CALCIUM STEARATE || |
| DEXTROSE MONOHYDRATE || |
| MALTODEXTRIN || |
| MINERAL OIL || |
|Product Characteristics |
|Color ||brown (BROWN) ||Score ||no score |
|Shape ||ROUND ||Size ||6mm |
|Flavor || ||Imprint Code ||AP;330 |
|Contains || |
|# ||Item Code ||Package Description ||Multilevel Packaging |
| 1 ||NDC:53002-1029-3 ||30 TABLET in 1 BOTTLE ||None |
| 2 ||NDC:53002-1029-0 ||100 TABLET in 1 BOTTLE ||None |
| Marketing Information |
|Marketing Category ||Application Number or Monograph Citation ||Marketing Start Date ||Marketing End Date |
|unapproved drug other || ||11/11/2010 || |
|Labeler — RPK Pharmaceuticals, Inc.
| Establishment |
|Name ||Address ||ID/FEI ||Operations |
|RPK Pharmaceuticals, Inc. || ||147096275 ||RELABEL (53002-1029), REPACK (53002-1029) |
Revised: 12/2020 RPK Pharmaceuticals, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.